Antiarrhythmogenic effect of omega-3 fatty acid ethyl esters in a patient treated with Omacor after a non-Q-wave myocardial infarction
An 84-year-old man reported several episodes of palpitations over the previous 6 months. He had a history of a prior non-Q-wave myocardial infarction (MI) and had received a dual-chamber pacemaker for control of subsequent sick sinus syndrome. Pacemaker data revealed 8000 premature ventricular beats...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-02-01
|
Series: | Journal of Arrhythmia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1880427613000768 |
Summary: | An 84-year-old man reported several episodes of palpitations over the previous 6 months. He had a history of a prior non-Q-wave myocardial infarction (MI) and had received a dual-chamber pacemaker for control of subsequent sick sinus syndrome. Pacemaker data revealed 8000 premature ventricular beats (PVBs) daily and nonsustained ventricular tachycardia (NSVT).
The patient agreed to add omega-3 fatty acid ethyl ester supplementation (1 g/day) to his treatment regimen. Pacemaker analyses 3 months later demonstrated no NSVT and only 215 PVBs daily. In more than 1 year of follow-up, the patient has remained well and has had no further ventricular arrhythmias. We conclude that omega-3 fatty acid ethyl ester supplementation may be beneficial in post-MI patients with pacemakers who develop ventricular arrhythmias. |
---|---|
ISSN: | 1880-4276 |